• Lun. Apr 22nd, 2024

vaccine

  • Home
  • mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines

mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines

The University of Texas MD Anderson Cancer Center and CureVac N.V. today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between…

CDC updates and simplifies respiratory virus recommendations

CDC released today updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from…